These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Integration of Population-Level Genotype Data with Functional Annotation Reveals Over-Representation of Long Noncoding RNAs at Ovarian Cancer Susceptibility Loci. Reid BM; Permuth JB; Chen YA; Teer JK; Monteiro AN; Chen Z; Tyrer J; Berchuck A; Chenevix-Trench G; Doherty JA; Goode EL; Iverson ES; Lawrenson K; Pearce CL; Pharoah PD; Phelan CM; Ramus SJ; Rossing MA; Schildkraut JM; Cheng JQ; Gayther SA; Sellers TA; ; ; Cancer Epidemiol Biomarkers Prev; 2017 Jan; 26(1):116-125. PubMed ID: 28035019 [TBL] [Abstract][Full Text] [Related]
13. Role of common genetic variants in ovarian cancer susceptibility and outcome: progress to date from the Ovarian Cancer Association Consortium (OCAC). Bolton KL; Ganda C; Berchuck A; Pharaoh PD; Gayther SA J Intern Med; 2012 Apr; 271(4):366-78. PubMed ID: 22443200 [TBL] [Abstract][Full Text] [Related]
14. Genetic epidemiology of ovarian cancer and prospects for polygenic risk prediction. Jones MR; Kamara D; Karlan BY; Pharoah PDP; Gayther SA Gynecol Oncol; 2017 Dec; 147(3):705-713. PubMed ID: 29054568 [TBL] [Abstract][Full Text] [Related]
15. Genome-wide association study identifies new susceptibility loci for epithelial ovarian cancer in Han Chinese women. Chen K; Ma H; Li L; Zang R; Wang C; Song F; Shi T; Yu D; Yang M; Xue W; Dai J; Li S; Zheng H; Wu C; Zhang Y; Wu X; Li D; Xue F; Li H; Jiang Z; Liu J; Liu Y; Li P; Tan W; Han J; Jie J; Hao Q; Hu Z; Lin D; Ma D; Jia W; Shen H; Wei Q Nat Commun; 2014 Aug; 5():4682. PubMed ID: 25134534 [TBL] [Abstract][Full Text] [Related]
16. TP53 mutations are common in all subtypes of epithelial ovarian cancer and occur concomitantly with KRAS mutations in the mucinous type. Rechsteiner M; Zimmermann AK; Wild PJ; Caduff R; von Teichman A; Fink D; Moch H; Noske A Exp Mol Pathol; 2013 Oct; 95(2):235-41. PubMed ID: 23965232 [TBL] [Abstract][Full Text] [Related]
17. Impact of insomnia on ovarian cancer risk and survival: a Mendelian randomization study. Wang H; Reid BM; Richmond RC; Lane JM; Saxena R; Gonzalez BD; Fridley BL; Redline S; Tworoger SS; Wang X EBioMedicine; 2024 Jun; 104():105175. PubMed ID: 38823087 [TBL] [Abstract][Full Text] [Related]
18. Integrative multi-omics analyses to identify the genetic and functional mechanisms underlying ovarian cancer risk regions. Dareng EO; Coetzee SG; Tyrer JP; Peng PC; Rosenow W; Chen S; Davis BD; Dezem FS; Seo JH; Nameki R; Reyes AL; Aben KKH; Anton-Culver H; Antonenkova NN; Aravantinos G; Bandera EV; Beane Freeman LE; Beckmann MW; Beeghly-Fadiel A; Benitez J; Bernardini MQ; Bjorge L; Black A; Bogdanova NV; Bolton KL; Brenton JD; Budzilowska A; Butzow R; Cai H; Campbell I; Cannioto R; Chang-Claude J; Chanock SJ; Chen K; Chenevix-Trench G; ; Chiew YE; Cook LS; DeFazio A; Dennis J; Doherty JA; Dörk T; du Bois A; Dürst M; Eccles DM; Ene G; Fasching PA; Flanagan JM; Fortner RT; Fostira F; Gentry-Maharaj A; Giles GG; Goodman MT; Gronwald J; Haiman CA; Håkansson N; Heitz F; Hildebrandt MAT; Høgdall E; Høgdall CK; Huang RY; Jensen A; Jones ME; Kang D; Karlan BY; Karnezis AN; Kelemen LE; Kennedy CJ; Khusnutdinova EK; Kiemeney LA; Kjaer SK; Kupryjanczyk J; Labrie M; Lambrechts D; Larson MC; Le ND; Lester J; Li L; Lubiński J; Lush M; Marks JR; Matsuo K; May T; McLaughlin JR; McNeish IA; Menon U; Missmer S; Modugno F; Moffitt M; Monteiro AN; Moysich KB; Narod SA; Nguyen-Dumont T; Odunsi K; Olsson H; Onland-Moret NC; Park SK; Pejovic T; Permuth JB; Piskorz A; Prokofyeva D; Riggan MJ; Risch HA; Rodríguez-Antona C; Rossing MA; Sandler DP; Setiawan VW; Shan K; Song H; Southey MC; Steed H; Sutphen R; Swerdlow AJ; Teo SH; Terry KL; Thompson PJ; Vestrheim Thomsen LC; Titus L; Trabert B; Travis R; Tworoger SS; Valen E; Van Nieuwenhuysen E; Edwards DV; Vierkant RA; Webb PM; ; Weinberg CR; Weise RM; Wentzensen N; White E; Winham SJ; Wolk A; Woo YL; Wu AH; Yan L; Yannoukakos D; Zeinomar N; Zheng W; Ziogas A; Berchuck A; Goode EL; Huntsman DG; Pearce CL; Ramus SJ; Sellers TA; ; Freedman ML; Lawrenson K; Schildkraut JM; Hazelett D; Plummer JT; Kar S; Jones MR; Pharoah PDP; Gayther SA Am J Hum Genet; 2024 Jun; 111(6):1061-1083. PubMed ID: 38723632 [TBL] [Abstract][Full Text] [Related]
19. FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patients. Tassi RA; Todeschini P; Siegel ER; Calza S; Cappella P; Ardighieri L; Cadei M; Bugatti M; Romani C; Bandiera E; Zanotti L; Tassone L; Guarino D; Santonocito C; Capoluongo ED; Beltrame L; Erba E; Marchini S; D'Incalci M; Donzelli C; Santin AD; Pecorelli S; Sartori E; Bignotti E; Odicino F; Ravaggi A J Exp Clin Cancer Res; 2017 May; 36(1):63. PubMed ID: 28482906 [TBL] [Abstract][Full Text] [Related]
20. Common Genetic Variation and Susceptibility to Ovarian Cancer: Current Insights and Future Directions. Kar SP; Berchuck A; Gayther SA; Goode EL; Moysich KB; Pearce CL; Ramus SJ; Schildkraut JM; Sellers TA; Pharoah PDP Cancer Epidemiol Biomarkers Prev; 2018 Apr; 27(4):395-404. PubMed ID: 28615364 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]